Polarean Imaging (GB:POLX) has released an update.
Polarean Imaging PLC, a leader in advanced MRI technology for lung function, has appointed its co-founder, Bastiaan Driehuys, as a consultant while continuing his role as Chief Scientific Officer. Dr. Driehuys, who invented hyperpolarised gas MRI and has been instrumental in developing Polarean’s technology, will contribute his expertise after stepping down from the Board. Polarean is known for its FDA-approved hyperpolarised Xenon MRI contrast agent, XENOVIEW™, which addresses chronic respiratory diseases.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
